首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >β1- and β2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart
【2h】

β1- and β2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart

机译:人胚胎干细胞衍生的心肌细胞中的β1-和β2-肾上腺素能受体反应:与成年和未成年人类心脏的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and purpose:Characterization of human embryonic stem cell-derived cardiomyocytes (hESC-CM) in relation to adult myocytes is essential for their future use in transplantation or as a model system. The β-adrenoceptor pathways, which are known to be effective early in hESC-CM development, are of major importance because of their control of rate and force of beating, arrhythmia generation and apoptosisecrosis. We have therefore performed detailed pharmacological analysis of the β-adrenoceptor responses in developing hESC-CM.
机译:背景和目的:与成年心肌细胞有关的人类胚胎干细胞来源的心肌细胞(hESC-CM)的表征对于它们将来在移植中或作为模型系统的使用至关重要。已知在hESC-CM发育早期有效的β-肾上腺素受体途径,由于其控制搏动的速率和作用力,心律不齐的产生以及细胞凋亡/坏死的作用而具有重要意义。因此,我们对发育中的hESC-CM中的β-肾上腺素受体反应进行了详细的药理分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号